Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by okgonowon Mar 07, 2024 2:30pm
26 Views
Post# 35921072

RE:So when LABS CEO stated they have over 20 'strong' clinical

RE:So when LABS CEO stated they have over 20 'strong' clinical
subaru1i wrote: trials, many in late stage then you have to ask yourself where are they all being conducted?  We already know the "who"...with their 'large traditional global phamaceutical partner' and NOT by coincidence, Pfizer hooked up with USC way back in 2013 for new 'innovative' solutions including cancer.   That 2013 hook up between Pfizer and USC...where the LABS Libby study is being conducted, the timing of 2013 hooks up to having over 20 strong clincial trials, many in LATE STAGE.....ie PHASE 3.  





a year ago...............tgere are cobwebs on that NR
<< Previous
Bullboard Posts
Next >>